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Abstract
We here report the first comparative proteomics of purified yeast post-Golgi vesicles (PGVs).
Vesicle samples isolated from PGV-accumulating sec6-4 mutants were treated with isobaric tags
(iTRAQ) for subsequent quantitative tandem mass spectrometric analysis of protein content. After
background subtraction, a total of 66 vesicle-associated proteins were identified, including known
or assumed vesicle residents as well as a fraction not previously known to be PGV associated.
Vesicles isolated from cells lacking the polarity protein Sro7p contained essentially the same
catalogue of proteins but showed a reduced content of a subset of cargo proteins, in agreement
with a previously shown selective role for Sro7p in cargo sorting.
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Protein secretion in yeast is a polarized growth process by which newly synthesized proteins
are transported through the secretory pathway to predestined sites at the plasma membrane.
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Following transport from the endoplasmic reticulum (ER) through the Golgi complex,
secreted proteins are sorted into transport vesicles that move to the cell surface along
polarized actin tracks, driven by myosin motor proteins (1). At the delivery site the vesicles
fuse with the plasma membrane by the process of exocytosis. A large eight-protein complex,
termed the exocyst, has a critical role in determining the attachment sites and tethers
outbound vesicles to the plasma membrane (2,3). Subsequent fusion of the vesicles with the
membrane is mediated by interaction with the plasma membrane target SNARE (t-SNARE)
proteins Sso1/2p (4) and Sec9p (5), and the vesicle SNARE (v-SNARE) proteins Snc1/2p
(6). SNARE proteins on opposing membranes form a complex which brings the membranes
in close proximity, catalyzing fusion. Small GTPases are master regulators of the tethering
and fusion processes by recruiting partner proteins (‘effectors’) to the membrane sites where
they are bound. In yeast, the GTPase Sec4p has a key role in controlling the process of
exocytosis (7,8). Many of the genes essential for secretion in yeast were identified in a
screen for conditionally lethal mutations in which protein transport was arrested at various
stages (9). Mutations in 10 of the isolated sec genes caused accumulation of post-Golgi
trafficking vesicles when mutants were incubated at restrictive temperature. This phenotype
has allowed the development of a procedure to isolate purified post-Golgi vesicles (PGVs)
in sufficient amounts to perform detailed molecular analysis (10).
Sro7p is a yeast member of the family of Lethal giant larvae (Lgl) proteins, which are
involved in cell polarity establishment in various organisms (11,12). In yeast, Sro7p plays a
regulatory role in late exocytosis by physical interaction with myosins (13,14), the t-SNARE
Sec9p (14,15), the exocyst subunit Exo84p (16) and Sec4p in its GTP loaded form (17).
When exocytic vesicles arrive onto sites of plasma membrane growth, Sec4p-GTP is
suggested to help initiating SNARE complex assembly via the transiently formed ternary
complex (18). According to this model, the Sec4p-mediated signal will stimulate release of
Sec9p from its inhibitory interaction with Sro7p, thereby allowing Sec9p to take part in
SNARE complex formation and vesicle fusion with the plasma membrane. In Drosophila,
the Lgl tumor suppressor protein is required to maintain epithelial cell polarity during
embryogenesis and to establish asymmetric cell division and proper cell fate determination
in the developing nervous system (11,19,20). An important aspect of Lgl function in these
processes is its role in establishing polarized membrane domains by directing specific
proteins to distinct regions of the plasma membrane. The asymmetric distribution of fate
determinants in neural precursor cells involves intricate interactions with the Par polarity
complex (21–23), but the detailed mechanisms for the role of Lgl in protein targeting are yet
to be determined.
We have observed that yeast mutants lacking SRO7 become sensitive to NaCl stress (24)
because of insufficient delivery of Ena1p, the sodium pumping ATPase, to the cell surface
(25). Instead, Ena1p is directed to the vacuole for degradation, via the multivesicular body
(MVB) pathway. This retargeting of Ena1p in sro7Δ mutants appears to occur at the late
Golgi level. Consistent with this supposition, Ena1p-GFP is mainly detected in endosomes
and vacuoles in sro7Δ mutants grown at high salinity, and we failed to detect Ena1p cargo in
PGVs isolated from these mutants (25). In contrast, similarly treated sec mutants arrested in
late exocytosis showed a clear accumulation of Ena1p in the isolated trafficking vesicles.
Hence, missorting of Ena1p appeared not because of the well-established role for Sro7p in
late exocytosis, but rather to a defect occurring in Golgi-mediated protein sorting (25).
These findings indicated a second role for Sro7p in protein trafficking. Interestingly, this
function occurs at Golgi – the main site for polarized protein sorting in the cell (26).
To shed further light on the role of Sro7p in protein secretion, we used quantitative
proteomics to analyze the protein content in PGVs and as a means to specify what proteins
are affected in their trafficking to the plasma membrane when SRO7 is lacking. Using this
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analysis we identified new residents of the PGVs and showed that Sro7p is required for
correct secretion of a specific subset of cargo proteins in cells subjected to NaCl stress.
Results
Isolation and analysis of post-Golgi secretory vesicles
To isolate highly purified post-Golgi secretory vesicles we followed a modified version
(5,27) of the well-established protocol of Walworth and Novick (10). Vesicles isolated by
this procedure are morphologically homogenous and contain low levels of contaminating
membranes. The protocol takes advantage of the accumulation of trafficking vesicles in the
late acting secretory mutant, sec6-4, when shifted to restrictive temperature (37°C). As we
also wanted to follow the secretion of the NaCl-induced sodium pump Ena1p (28,29), which
is known to be missorted in sro7Δ cells under saline conditions (25), our protocol involved a
shift of cells to high salinity medium to allow for identification of other cargo molecules that
show dependence on Sro7p for correct delivery to the cell surface under these conditions.
We first applied the protocol to a vesicle accumulating sec6-4 strain and a sec23-1 mutant
that becomes depleted of vesicles at restrictive temperature because of an early block in
secretion (30). This obstruction makes the sec23-1 mutant suitable for the preparation of
‘mock vesicle fractions’ that contain little genuine PGVs but contaminating proteins that co-
purify with vesicle fractions in general (31). The vesicle-enriched P3 fraction obtained by
differential centrifugation of lysed cells was layered onto a sorbitol gradient (5). Following
velocity gradient centrifugation the gradients were fractionated and analyzed by
immunoblotting for the presence of the SNARE proteins Sso1/2p and Snc1/2p (Figure 1A).
Both markers yielded a coincident peak in the middle of the gradient for the sec6-4 mutant.
A summary of the enrichment steps for a typical purification is given in Table 1. After
gradient centrifugation the three pooled peak fractions showed a 41-fold enrichment of the
PGV marker v-SNARE Snc1/2p over the total cell lysate. The pooled fractions were used
for the subsequent proteomic analysis of the vesicles. Samples from sec23-1 and sec6-4
were solubilized, digested with trypsin and labeled for quantitative proteomic analysis using
iTRAQ tags (isobaric tags for relative and absolute quantification) that generate amine-
derivatized peptides (32). The derivatized peptides exhibit mass spectrometry (MS)
signature ions that permit determination of their relative abundance in the original sample
allowing for quantification of the parent proteins.
Delimitation of vesicle proteins
Using this approach, the protein composition of purified vesicles was analyzed by LC-MS/
MS (liquid chromatography-tandem mass spectrometry). From the 1382 peptides that were
conclusively assigned, 242 different proteins were identified from sec6-4 control and
sec23-1 mock fractions. A complete list of identified proteins is given in Table S1. Most
proteins showed modest differences between control and mock values; about half of the set
(51%) had normalized control/mock ratios between 2 and the observed lowest value, 0.4,
and 15% had ratios ≤1. To define a set of proteins significantly enriched in the control
vesicle fractions (depleted from the mock fraction), we applied a threshold ratio of >2.5, a
conservative cutoff corresponding to the ratio for the vesicle t-SNARE, Sso2p. This protein
catalogue, shown in Table 2, included 91 proteins with enrichment ratios between 2.5 and
50. The applied threshold selected a set of proteins significantly (Fisher’s exact test,
Bonferroni correction, p < 0.1) enriched for specific cellular functions [comparison made to
all proteins that had a chance of occurring in the set, i.e. excluding dubious open reading
frames (ORFs)], many of them associated with plasma membrane-related activities (Figures
2 and S2). The observed enrichment for the v-SNARE and the vesiclemarker Snc2p (sixfold,
Table 2) was in good agreement with the enrichment obtained for the marker by
quantification of immunoblot signals (Figure 1B,C).
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To identify likely false positives in the assigned vesicle inventory, we first picked out high-
abundance proteins previously shown to have a mainly cytosolic distribution. The selected
seven proteins (marked with a double asterisk in Table 2) are all among the top 6% of the
most abundant proteins in the cell (33). These proteins, primarily glycolytic enzymes, are
very probable contaminants because they may co-purify with the enriched vesicle pool
simply because of their extreme cellular abundance, exceeding the overall cellular
abundance of most vesicle proteins by three orders of magnitude (33,34). We also identified
18 proteins, which, according to their presently known function/localization, are unlikely
PGV cargo molecules (marked with a single asterisk). When eliminating the 25 assumed
false positives (28%), a component list of 66 predicted high-confidence PGV residents
remained.
Functional analysis of assigned vesicle proteins
Analysis of the characteristics of the protein catalogue in Table 2 showed a defined set of
functions, targeted for a distinct set of cellular compartments (Figures 2, 3 and S2). In
particular, proteins found in, or associated to,membrane structures are significantly enriched
(Fisher’s exact test, Bonferroni correction, p < 0.1) in the defined set as compared to the
control group of proteins (determined as described above). The localization categories
should be viewed with the awareness that most proteins are annotated to multiple categories
(average of 3.6 in the current set). For example, among the 29 proteins annotated as
mitochondrial residents (Figure S2, Table 2), 9 are also reported to be localized to the
plasma membrane (Dnf1p, Ecm33p, Gnp1p, Mrh1p, Pdr5p, Pma1p, Snq1p, Yjl171cp,
Yju8p), 2 are found in plasma membrane enriched fractions (Faa1p, Msc1p), 4 have roles in
cell wall assembly (Fks1p, Fks3p, Gas1p, Sac1p), 3 are involved in cell polarity (Rho1p,
Yro2p, Rtn1p) and 8 have regulatory or other functions in the secretory process (Ypt31,
Spf1p, Ste24, Tsc13, Vps21, Ypt1, Ypt7 and Yro2). The remaining four (Eht1p, Erg6p,
Gcn1p and Grx2p) have been indicated as putative contaminants in our preparations (see
Table 2). Hence, most of the proteins in the mitochondrial category also have localizations
compatible with PGV transport.
Among the nine proteins that were most highly (>10-fold) enriched in sec6-4 relative to
mock preparations, seven were cellwall-associated proteins (Table 2). Bgl2p, the cell wall
endo-β-1,3-glucanase (35) and a marker for secretory vesicles (10), belonged to this group.
Notably however, three other vesicle markers, invertase (Suc2p), acid phosphatase, and exo-
β-1,3-glucanase (Exg1p), were absent from our preparations, probably because of repressed
production under our growth conditions (high concentration of glucose, phosphate and
NaCl, respectively). A predominant fraction, 61% of the vesicle-associated proteins, was
membrane proteins, many of which being established or presumed plasma membrane
transporters (Dnf1p, Ena1p, Gnp1p, Hxt5p, Hxt7p, Agp1, Pdr5p, Pma1p, Ptr2p, Snq2p and
Stl1p). Besides the major fraction of cargo proteins, the vesicles also held proteins with
membrane identifying and regulatory roles. This group included the v-SNARE Snc2p and t-
SNARE Sso2p, and a set of small GTPases that serve as spatial signals and regulators of
membrane traffic. Snc1p and Sso1p were not confidently identified because of an
insufficient number of identified unique peptides. Three of the identified GTPases, Sec4p,
Cdc42p and Rho1p, are directly involved in controlling trafficking of PGVs and have an
earlier established association with late-secretory vesicles (36–38). Rho1p is also a regulator
of another vesicle resident, Fks1p, the catalytically active subunit of the 1,3-β-D-glucan
synthase, involved in cell wall remodeling (39). Another regulatory subset, Ypt1p and
Ypt31p, function as key controlling factors in trafficking to, within and from Golgi, whereas
Vps21p and Ypt7p regulate aspects of endocytosis and Golgi–to-vacuole transport (40).
Interestingly, previous immuno-electron microscopy has demonstrated that Ypt1p, one of
the above GTPases that has no known role in exocytosis, is associated with Golgi-derived
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secretory vesicles (41). Our preparation also contained a lipid modifying
phosphatidylinositol phosphatase (Sac1p) and two aminophospholipid translocases (Drs2p,
Dnf1p) that may affect vesicle budding by regulating lipid composition of Golgi and plasma
membrane (42,43). Another noteworthy group was constituted by mannosyltransferases
involved in post-translational modification of proteins belonging to the KTR (Ktr1p, Ktr3p
and Kre2p) family, having a role in cell wall mannoprotein synthesis and protein
glycosylation at the Golgi (44). A vesicle-associated protein kinase was also uncovered,
Kic1p that regulates 1,6-β-glucan levels in the cell wall (45). Notable is also the presence of
a subunit, Sss1p, of the Sec61p translocon complex and two subunits of the vacuolar H+-
ATPase (V-ATPase) (46); the V1 sector subunit Vma13p and the V0 transmembrane sector
subunit Vph1p (see Discussion).
Comparative proteomics of vesicles isolated from sec6-4 and sro7Δ mutants
To identify proteins other than Ena1p that might display decreased trafficking to the plasma
membrane in mutants lacking SRO7, we isolated PGVs from an sro7Δ strain subjected to the
same salinity and temperature regime as previously described (Figure S1). The isolation of
vesicles from sro7Δ mutants is facilitated by the fact that these mutants accumulate PGVs
when exposed to high salinity (25) at which condition the missorting of Ena1p is also
observed. All of the 91 assigned sec6-4 vesicle residents were present as high-confidence
PGV proteins also in the corresponding sro7Δ fractions, demonstrating excellent
reproducibility for the performed analysis (Table S2). Further analysis revealed no obvious
cell function or component that was specifically affected by the deletion of SRO7 (Figures 2
and 3). However, a difference that stands out is the apparent depletion of a subset of proteins
from the vesicles of the sro7Δ strain (Table S2). As Ena1p, the main plasma membrane
sodium pump, was previously reported to be diverted from PGVs in sro7Δ mutants exposed
to NaCl stress (25), we used the Ena1p distribution as an arbitrary threshold to define
proteins that display depletion in sro7Δ vesicles. Somewhat surprisingly, Ena1p was only
partly depleted in our present analysis of sro7Δ vesicles (sro7Δ/sec6-4 ratio of 0.7, Table 3),
in contrast to the previous observations in which Ena1p failed to be detected insro7Δ PGVs,
as determined by immunoblot of HA-tagged Ena1p (25). This discrepancy may at least
partly stem from different experimental conditions; the present experiments were conducted
at 37°C, whereas in the previous investigation the sro7Δ mutant was kept at 25°C. This
modification is expected to affect the results, because the salt-sensitive phenotype of sro7Δ
is weakened, although not abolished, at high temperatures (I. Wadskog, unpublished data).
Using the Ena1p-based cutoff, 22 candidate proteins were identified as depleted in sro7Δ
vesicles, showing sro7Δ/sec6-4 ratios from 0.3 to 0.7 (Table 3, Figure 4). Seven of these
proteins (Cwp1p, Pir1p, Ygp1p, Bgl2p, Crh1p, Gas5p and Pst1p) are involved in cell wall
functions. In agreement with these observations, secretion of the endo-β-1,3-glucanase,
Bgl2p was previously shown to be defective in salt stressed sro7Δ mutants (25). It is also of
interest that the vesicle fusion controlling Snc2p and Sec4p belong to the candidates for
depletion in sro7Δ vesicles, as did three plasma membrane transporters: the glycerol proton
symporter Stl1p, the main high-affinity glucose transporter Hxt7p and Ena1p. To validate
the observed depletion of PGV residents in sro7Δ mutants, the distribution of selected cargo
proteins was examined also by western blotting, using independently prepared vesicles from
sro7Δ and sec6-4. The enrichment ratios obtained by immunoblotting (Figure 5A) were in
agreement with those observed from iTRAQ data (Figure 5B), strongly corroborating the
distribution shown in Table 3.
Stl1p was the protein most depleted in sro7Δ PGVs, showing a sro7Δ/sec6-4 ratio of 0.3.
STL1 is a strongly salt-induced gene (47) that is subject to a temperature-alleviated glucose
repression (48), two reasons on why Stl1p appears in our analysis. To further study the
selective depletion of proteins in sro7Δ vesicles, we followed the fate of a GFP-tagged
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version of Stl1p in wild-type and sro7Δ cells, after consecutive shifts to high salinity and
37°C. Fluorescence micrographs, taken 2 h after induction of STL1-GFP production, showed
a clear GFP signal from the plasma membrane of wild-type cells, whereas in sro7Δ cells
there was a much weaker fluorescence from the membrane, most of the signal coming from
the vacuole (Figure 6A). A selective exclusion of Stl1p-GFP from sro7Δ vesicles was also
confirmed by western blotting of PGVs prepared from wild-type cells and sro7Δ mutants.
This assay showed an sro7Δ/wild-type distribution of Stl1p-GFP of about 0.3 (Figure 6B),
strongly supporting the depletion of Stl1p from sro7Δ PGVs shown by iTRAQ data (Table
3). We conclude that the described independent observations are all in agreement with a
defective sorting of Stl1p in sro7Δ PGVs.
As sro7Δ mutants apparently missort proteins encoded by two strongly salt-induced genes
(ENA1 and STL1), we explored the possibility that Sro7p exerts a general control over the
cellular response to NaCl stress. To this end, the NaCl tolerance of deletion mutants
corresponding to each of the proteins showing depletion in sro7Δ PGVs was assayed. As
demonstrated in Figure S3 the growth rate of these mutants was similar to that of wild-type
cells giving no support for a generic role of Sro7p in the cellular NaCl response.
Discussion
Here we report on the yeast secretory proteome based on quantitative proteomics of purified
PGVs. Using differential and velocity-gradient centrifugation, we purified secretory vesicles
achieving a 41-fold enrichment over the crude cell homogenate. The purification compares
favorably with previous reports (Ref. 27, #1190; Ref. 10, #1772) and the cargo enrichment
is similar to that of a previous iTRAQ-based proteomic analysis of clathrin-coated vesicles
from HeLa cells (31), in which the top 53 proteins considered to be bona fide vesicle
proteins displayed a control/mock ratio of 2- to 12-fold. The performed analysis allowed us
to study all of the PGVs that accumulate in late-secretory mutants, not just those associated
with a particular marker protein. Using this approach we identified, after background
subtraction, 66 proteins predicted to be specifically associated with exocytic vesicles (Table
2). As our report represents the first proteomic analysis of yeast PGVs, most of the identified
proteins have not formerly been recognized as vesicle residents. However, a considerable
share of the occupants is plasma-membrane proteins or cell wall-associated proteins and
therefore expected regular traffickers of these vesicles. It should be stressed that the
presented catalogue of proteins does not give a full account of PGV proteins. First, our
experimental conditions – in particular the choice of carbon source (glucose) and the
exposure of the cells to high salinity and temperature – will influence the selection of
proteins that travels with the vesicles. Second, the preparation procedure, especially the
fractioned centrifugation preceding the velocity-gradient step, may lead to loss of loosely
associated proteins and explain the absence of proteins known to interact peripherally with
the vesicle surface, such asMyo2p (49) and all the exocyst subunits except Sec3p (50).
Finally, small proteins having close homologs may generate too few unique tryptic peptides
to be reliably identified by MS analysis, leading to the failure of detecting the SNARE
proteins Snc1p and Sso1. However, the absence of known coat-complex proteins was
expected because the major routes from Golgi to the cell surface seem to involve
mechanisms of vesicle formation that do not depend on clathrin and conventional adapter
protein complexes (51,52). Coat proteins can, however, be involved when the secreted
protein is recycled between Golgi and endosomes on its way to the cell surface. The
trafficking of the chitin synthase, Chs3p, is awell-described example. This protein is kept in
a reservoir by traveling between Golgi and early endosomes, and the recycling is mediated
by clathrin and the AP-1 adaptor complex (53). Recruitment of Chs3p to the cell surface
from this reservoir requires another and highly specific coat complex, composed of the two
proteins Chs5p and Chs6p (54). Although coats are shed after vesicle budding, the complete
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absence of specific or classical coat proteins in our vesicle pools may reflect preparations,
showing little contamination by vesicles that traffic endocytic and ER-to-Golgi pathways.
The presence of three α-1,2-mannosyltransferases in the vesicle cargo was a notable feature
because these enzymes have a known Golgi-location, where they extend and modify O-
linked and N-linked glycans that have been attached to membrane- and secreted proteins in
the ER (44,55). Their residence in PGVs may simply reflect recycling between Golgi and
the plasma membrane, or suggest that protein glycosylation is occurring during transport to
and/or at the cell surface. Glycosylation may not only serve as a determinant specifying
surface delivery of proteins (56), but has important roles for the stabilization and proper
function of cell surface proteins, such as the glycoproteins of the outer cell wall layer (39).
Another striking observation is the presence of two subunits of the vacuolar H+-ATPase in
the vesicles. Although the V-ATPase has its main role in vacuolar acidification (46), it has
been implicated in synaptic exocytosis, and V0 subunits are reported to interact with
SNARE proteins on synaptic vesicles (57,58). Our results also strengthen the significance of
the recently described genetic interaction between SEC9 and genes encoding V-ATPase
subunits (59). Another seemingly paradoxical finding was the presence of a subunit of the
translocon in the vesicle cargo. This channel translocates proteins across the ER membrane
into the ER lumen and integrates proteins with transmembrane segments into the membrane
(60). However, there is strong genetic and physical evidence that the translocon interacts
with subunits of the exocyst (61,62), and it was suggested that this interaction may serve to
co-ordinate translation and protein translocation into ER with the activity of the secretory
machinery (63). These observations may serve as illustrating examples of the multiple,
diverse sub-cellular localization for most of the identified proteins.
Yeast has at least two different routes for transport from Golgi to the cell surface (27,64,65).
The situation in polarized epithelial cells is more complex. These cells have apical and
basolateral cell surfaces separated by junctions and the two membrane regions have distinct
physiological functions and protein composition. To establish and maintain this polarity, the
majority of apical and basolateral proteins are sorted in trans-Golgi and directed to the
appropriate surfaces via multiple pathways (26). Drosophila lgl mutants fail to establish
correct epithelial polarity during embryogenesis; proteins that are determinants of the apical
membrane become mislocalized to the basolateral domain (11). The specific role of Lgl in
restricting proteins to the apical domain of the cell membrane has not yet been fully
elucidated. We have previously reported that mutants lacking SRO7, the yeast Lgl ortholog,
become salt sensitive because of mistargeting of the main sodium pump, Ena1p, at high
salinity (24,25). Rather than being routed to the cell membrane, Ena1p is predominantly sent
to the vacuole for degradation in these mutants. To identify other possible candidates for
mistargeting, we here performed comparative proteomics of vesicles isolated from sec6-4
and sro7Δ strains at restrictive conditions. This analysis demonstrated that Ena1p is only
partly depleted from sro7Δ vesicles (Table 3), which contrasts with a previously reported
failure of detecting Ena1p in sro7Δ PGVs (25). The discrepancy may partly reflect different
experimental setup, as previously discussed. However, some vesicle-mediated transport of
Ena1p to the plasma membrane has to occur in sro7Δ mutants, because thesemutants are
lessNaCl sensitive than ena1Δ mutants (24), which are completely devoid of the sodium
pump. Data from the iTRAQ-based analysis (Table 3), supported by independently
performed immunoblots (Figure 5), showed that a subset of proteins was more strongly
depleted than Ena1p in sro7Δ vesicles. A substantial fraction of these 22 proteins comprised
cell-wall-associated proteins, involved in remodeling of the carbohydrate chains (Gas5p,
Bgl2 and Crh1p), or constituting cell wall proteins (Cwp1, Pir1p, Ygp1p and Pst1p).
Another noteworthy observation was the depletion of the v-SNARE Snc2p and the vesicle-
associated Rab GTPase, Sec4p, in sro7Δvesicles. As mutants defective in Snc1/2p (6) and
Sec4p (27) accumulate PGVs, the reduced presence of these fusion controlling proteins may
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be a contributing factor for the vesicle accumulation seen in the sro7Δ strain at high salinity
(25). This depletion might add to effects from the established role of Sro7p as a regulator of
SNARE function through its interaction with Sec9p (8,66). The protein that was most under-
represented in the sro7Δ vesicles was the glycerol/H+ symporter, Stl1p. Similarly to ENA1,
STL1 has a role in the osmotic stress response and is strongly and transiently induced by salt
stress (47). The mobilization of Stl1p serves to prevent leakage of glycerol, an
osmoregulator that accumulates in cells subjected to hyper-osmotic stress. Based on the fate
of Stl1p in sro7Δ mutants (Figure 6), it is tempting to suggest that Stl1p may travel together
with Ena1p and like the sodium pump be subject to diversion from the exocytic pathway in
sro7Δ mutants. However, none of the other proteins that were under represented in sro7Δ
PGVs appear to be important for NaCl tolerance (Figure S3), showing that Sro7p has a more
general role than sorting of proteins involved in sodium control.
The transit of proteins from Golgi to the cell surface has been much less studied than
trafficking of the early steps of the secretory pathway. We believe that the proteomic
analysis presented here may provide a useful basis for further elucidation of exocytic
processes. The use of this technique to examine the effect of the polarity protein Sro7p on
sorting into the vesicle compartment illustrates that the analysis can be applied to study
effects of particular factors on the composition of the proteome.
Materials and Methods
Strains and media
The Saccharomyces cerevisiae strains used in these experiments were BY2: Mat a; ura3-52,
BY37: Mat a; ura3-52; sec6-4, BY47: Mat a; ura3-52; sec23-1, and Mat a; ura3-52; sro7Δ:
LEU2 (BY2 background). Cultures were grown in YPD (1%Bacto Yeast Extract and
2%Bacto Peptone; Difco laboratories) or SD medium (0.17% YNB, 0.5% ammonium
sulfate) with 2% glucose and with the addition of 5 M NaCl to a final concentration of 0.6 M
where stated.
Purification of secretory vesicles
Cells were cultured at 25°C to early exponential phase (optical density at 610 nm (OD610) of
0.6–0.7) in 750 mL cultures of YPD medium. Following a shift to 0.6 M NaCl, incubation
was continued at 25°C for 2h and cultures were then shifted to 37°C for another 2 h. The
cells were harvested after addition of NaN3 and NaF (20 mM final concentration). To
account for the different degree of vesicle accumulation in the strains, 600 OD610 units were
harvested from the sec6-4 mutant, while 1800 OD610 units were taken from the wild type,
sec23-1 or the sro7Δ strains for the subsequent purification. Cells were washed in ice-cold
Tris buffer (10 mM Tris–HCl pH 7.5, 10 mM NaN3, 10mM NaF) and then treated by
previously described procedures with a few modifications (5,10,27). In short, cells were
resuspended in sphaeroplast buffer (0.1 M Tris–HCl pH 7.5, 1.4 M sorbitol, 10 mM NaN3,
0.001% beta-mercaptoethanol, 0.1 mg/mL zymolyase 100T) (Seikagaku) and incubated at
37°C for 30 min. The sphaeroplasts were collected at 2000 × g and resuspended in lysis
buffer containing 0.8 M sorbitol, 10 mM triethanolamine with 1 mM ethylenediaminetetraacetic
acid (EDTA) [adjusted to pH 7.2 with acetic acid (TEAE)], and protease inhibitor cocktail
(Roche Cat. No. 1873580). The sphaeroplasts were lysed by gentle resuspension and
pipetting in lysis buffer, and spun at 700 × g for 10 min generating the S1 supernatant. The
S1 fraction was centrifuged at 13 000 × g for 20 min yielding the S2 supernatant and P2
pellet. This supernatant was centrifuged at 100 000 × g for 1 h at 4°C in a 70.1 Ti rotor
(Beckman) generating the P3 membrane pellet and the S3 supernatant. The P3 pellet was
kept in lysis buffer on ice to dissolve for 2 h. The resuspended, vesicle enriched P3 fraction
was further purified by velocity gradient centrifugation. An 11mL linear sorbitol gradient
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was preparedwith 1.2 mL steps of 40%, 37.5%, 35%, 32.5% 30%, 27.5% 25%, 22.5% and
20% sorbitol (w/v) dissolved in 10 mM triethanolamine acetate with 1 mM EDTA (pH 7.2).
The resuspended P3 fraction was layered on top of the gradient and spun for 1 h at 71 000 ×
g at 4°C in an SW41 rotor (Beckman) and then fractionated from top to bottom in 16
fractions. The SNARE proteins Sso1/2p and Snc1/2p were detected in the gradient fractions
by immunoblotting.
Sample preparation and iTRAQ analysis
iTRAQ analysis was carried out essentially as described by Borner et al. (31). Selected peak
vesicle fractions from each gradient were concentrated by centrifugation for 1 h at 100 000 ×
g and 4°C in a 70.1 Ti rotor (Beckman). The resulting P4 vesicle pellets were resuspended in
2.5% SDS, 50 mM Tris, pH 8.0, heated to 65°C for 2min and centrifuged at 16 000 × g for 2
min. Protein in the supernatant was precipitated with 5 volumes of ice-cold acetone at
−20°C overnight. Precipitated proteins were solubilized in 100-µL 25-mM triethylammonium
bicarbonate (TEAB), pH 8.5, 8 M urea, 2% Triton-X-100 and 0.1% SDS (labeling buffer).
Protein concentration was determined using the BCA Protein Assay Kit (Pierce). Samples
were adjusted to equal protein concentration with 0.5 M TEAB, 75 µg per sample condition
was used for the labeling procedure. Each sample was reduced and alkylated as previously
described (32) before digestion with mass spectrometry grade trypsin (Promega). Digestion
was performed overnight and stopped by adding 0.1% formic acid and the total of one
iTRAQ reagent vial (Applied Biosystems) resolved in 70 µL ethanol to each peptide
mixture. Labeled peptides were pooled, lyophilized and resuspended in 250 µL 25mM
ammonium formate, 20% acetonitrile, pH 2.8. Strong cation exchange chromatography
(SCX) on the peptide fractionation was performed with an Ä ktaPurifier (Amershan
Pharmacia biotech) using a Polysulfoethyl A column 100 mm × 2.1 mm × 5 µm 300
Å(PolyLC). Peptideswere eluted by a 0–100% gradient toward 500 mM ammonium formate,
20% acetonitril, pH 2.8. Collected fractions were lyophilized and resolved in 0.1% formic
acid.
Mass spectrometry analysis
Two-microliter sample injections were made with a HTC-PAL autosampler (CTC Analytics
AG) equipped with a Cheminert valve (0.25 mm bore, C2V-1006D-CTC, Valco Instruments
Co), connected to an Agilent 1200 binary pump (Agilent Technologies). The peptides were
trapped on a precolumn (45 × 0.075 mm i.d.) packed with 3 m C18-bonded particles and
separated on a reversed phase column, 200 × 0.050 mm, both columns were packed in-house
with 3 µm Reprosil-Pur C18-AQ particles (Dr. Maisch GmbH, Ammerbuch-Entringen). A
40-min gradient 10–50% acetonitrile in 0.2% formic acid was used for separation of the
peptides. Nanoflow LC-MS/MS was performed on a hybrid linear LTQ-Orbitrap mass
spectrometer (LTQ Orbitrap XL, Thermo Scientific) equipped with a nanospray
sourcemodified in-house. The spectrometer was operated in a data-dependentmode, both MS
and MS/MS scans were obtained in Orbitrap. For each MS, the three most intense doubly
and triply charged ions were fragmented by higher energy C-trap dissociation (HCD). MS/
MS were collected in profiled mode with the first mass fixed m/z at 100 Da to include the
iTRAQ reporter ions in the every scan.
MS data acquisition and protein quantification
RAW MS files were converted into a centroid and profiled mxXML file using ReadAw
(http://sourceforge.net/projects/sashimi/files/). Both files were further processed into two
peaklists using mzXML2Search (Part of the Trans-Proteomics-pipeline, http://
sashimi.sourceforge.net/software_tpp.html). Database searches were performed on the
centroid peaklist using MASCOT (v2.2.01, Matrixscience) against all Saccharomyces cerevisiae
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proteins in the SWISSPROT database (release 55.3) containing 6833 entries. Search parameters
were peptide mass tolerance 5 p.p.m. and a 0.5 Da mass window for the MS/MS. One
trypsin miss cleavage was allowed, fixed modification methylthio (C), iTRAQ4plex (K and
N-terminal), variable modification oxidation of methionine. Protein identifications were
excepted when based on >1 unique peptides with >95% confidence. iTRAQ quantification
was performed using the perl script version of i-tracker (67), extracting the area under the
different iTRAQ reporter ions from the profiled peak list. Peptide identification and
quantification were combined using an in-house script, all data were exported into Microsoft
Excel for statistical analysis. Combined iTRAQ ratios were set to one for each peptide
identification, ratios were calculated for sro7Δ/sec23-1, sec6-4/sec23-1 and sro7Δ/sec6-4.
Average of the log2 for all assigned peptide ratios per proteins was used for protein
quantification, and fold regulation was defined as ±1 SD from the median of all quantified
proteins in a sample-to-sample comparison (32). For determination of relative abundance of
proteins in control and mock PGVs (control/mock ratios), normalization of protein
abundance was performed after excluding ribosomal proteins, because ribosomes are in the
same size range as exocytic vesicles and therefore expected co-purificants (68).
Western blot analysis
The prepared P4 pellets were resuspended in lysis buffer and samples were heated in sample
buffer at 95°C for 5 min (or 15 min at 65°C for STL1-GFP) and resolved by SDS–PAGE on
12.5 or 10% Tris–HCl gels (Biorad). Separated proteins were transferred to nitrocellulose
membrane for western blot with rabbit antiserum against Sso1p/2p, Snc1p/2p, Bgl2p,
Cwp1p, Gas1p ormouse anti-GFP antibody (Roche Cat. No. 11814460001). Secondary
antibody was either Alexa Fluor 680 goat anti-rabbit or Alexa Fluor 680 goat anti-mouse
(Invitrogen). The blots were analyzed with the Odyssey Infrared Imaging System (LI-COR)
and quantitated using the ODYSSEY quantification software (version 2.1).
Fluorescence microscopy
For fluorescence microscopy, mid-exponential cultures of wild-type and sro7Δ cells
carrying Stl1p-GFP expressed from the MET25 promoter of a pUG35 plasmid (kindly
provided by Dr. Anders Brandt) were shifted to fresh methionine-free medium with 0.6 M
NaCl and were incubated for 2 h at 37°C prior to microscopy. Cells were viewed with a
LEICA DMRXA microscope (Deerfield) using a Fluotar lens and the Leica 513852 filter for
the GFP channel. Photographs were captured using a Hamamatsu ORCA cooled CCD
camera (Bridgewater).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Distribution of the post-Golgi vesicle marker Snc1/2p and Sso1/2 in sorbitol vesicle
gradient fractions from sec6-4 and sec23-1 strains
A) Cells were cultured and lysates prepared and fractioned as described in Materials and
Methods. Samples from each fraction of the gradient were heated in sample buffer at 95°C
for 5 min, and resolved by SDS–PAGE on 12.5% Tris–HCl gels (Biorad). Separated
proteins were transferred for western blot with antiserum against Sso1/2p and Snc1/2p. B)
Distribution profile of Snc1/2p in the vesicle gradient fractions from sec6-4 and sec23-1
strains. The three peak fractions from the sec6-4 gradient were used for subsequent analysis.
For the mock strain (sec23-1), fractions corresponding to the sec6-4 peak fractions were
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used. C) Relative strength of Snc1/2p signals from peak fractions 7, 8 and 9 of the sec6-4
and sec23-1 preparations.
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Figure 2. Sub-cellular enrichment of vesicle proteins prepared from sec6-4 (open bars) and sro7Δ
(filled bars) strains
Vesicle proteins were defined as proteins >2.5-fold more abundant in sec6-4 or sro7Δ
fractions relative to the mock (sec23-1) strain. All sub-cellular compartment annotations
were significantly enriched relative to the random expectation according to Fisher’s exact
test (Bonferroni correction, p < 0.1) for either sec6-4 or sro7Δ. Localization annotations
were from the Gene Ontology classification system as represented in the SGD yeast GO
slim component catalogue (http://www.yeastgenome.org/cgi-bin/GO/goSlimMapper.pl).
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Figure 3. Functional classification of proteins in vesicles prepared from sec6-4 (red bars) and
sro7Δ (blue bars) strains
Annotations were derived from the functional ontology classification system hosted by the
MIPS Comprehensive Yeast Genome Database (http://mips.helmholtz-muenchen.de/genre/
proj/yeast/Search/Catalogs/catalog.jsp). Enrichment was determined as in Figure 2. Only
functional processes with at least 15 annotated members were considered in the test.
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Figure 4. Top 15 proteins depleted in vesicles from cells lacking SRO7
Annotations and enrichment were determined as in Figure 2.
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Figure 5. Abundance of selected vesicle proteins analyzed in Table 3
A) An equal amount of protein from purified vesicles prepared from sro7Δ and sec6-4
mutants was subjected to immunoblotting as described in Materials and Methods. Protein
bands of expected sizes were quantitated and results illustrated in the bar graphs (right). B)
A bar graph of log(2) transformed ratio values comparing the sro7Δ/sec6-4 ratio from
immunoblot with the corresponding iTRAQ values. Samples for iTRAQ analysis and
immunoblot quantification were independently prepared.
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Figure 6. Localization of Stl1p-GFP in wild-type and sro7Δ cells
Fluorescence images show the distribution of Stl1p-GFP in (A) wild type and (B) sro7Δ
cells. Cells carrying a pUG35 STL1-GFP plasmid were grown to early exponential phase in
medium with 500 µM methionine. NaCl was added to a final concentration of 0.6 M and
incubation was continued for 2 h. Synthesis of Stl1p-GFP was induced by a shift to
methionine-free medium (with 0.6 M NaCl) and incubation was continued for 2 h at 37°C. C)
Distribution of Stl1p-GFP in purified PGVs from wild-type and sro7Δ strains. Cells
transformed with the pUG35-STL1 plasmid were harvested after a 2 h shift to 0.6 M NaCl,
followed by a 2 h shift to methionine free medium of the same salinity (to allow for
Forsmark et al. Page 21













induction of Stl1p-GFP) and 37°C. Purified PGVs were subjected to SDS–PAGE as
described in Materials and Methods and Stl1p-GFP was detected by immunoblotting with
anti-GFP antibody. Bands were quantitated (bar graph) and the Stl1p-GFP protein ratio in
PGVs from sro7Δ relative to wild type estimated to 0.33.
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Table 1








Lysate 36.3 51.4 1.4
S2 7.5 18.1 2.4 1.7
P2 4.2 27.1 6.4 4.6
P3 2.3 47.7 17.4 12.2
P4 0.31 18.1 58.4 41.1
Samples taken from each fraction during the purification process were subjected to SDS–PAGE and immunoblotting as described in Materials and
Methods. The intensity of the vesicle marker Snc1/2p was analyzed using the ODYSSEY quantification software and related to loaded amount of
protein to determine ‘specific intensity’.
Abbreviations: S2 and P2 are supernatant and pellet, respectively, following a 13 000 × g spin of the S1 supernatant, which was recovered after a
700 × g spin of lysed sphaeroplasts. P3: pellet generated by a 100 000 × g spin of S2. P4: pellet remaining following a 100 000 × g spin of the
pooled peak vesicle fractions from velocity gradient centrifugation of P3. For further details, see Materials and Methods.
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Table 2
Proteins more than 2.5-fold enriched in contol (sec6-4) PGV fractions relative to the corresponding mock
(sec23-1) fractions
Protein Molecular function Cellular distribution sec6-4/sec23-1 Peptides found
CWP1 Structural constituent of cell wall Cell wall, membrane 50.1 9
PIR1 Structural constituent of cell wall Cell wall 34 2
YGP1 Cell-wall-related secretory glycoprotein Extracellular region 29.5 9
STL1 Glycerol transporter Plasma membrane, membrane 15.7 3
BGL2 Glucan 1,3-beta-glucosidase activity Cell wall 15.6 8
GAS5 1,3-beta-glucanosyltransferase activity Cell wall, membrane fraction 14.7 2
CRH1 Probable glycosidase Cell wall 13.5 5





PST1 Cell wall mannoprotein Plasma membrane, cell wall,
membrane
12.3 5








PHM7 Phosphate metabolism protein Cell periphery, cytoplasm, vacuole 9.2 3
PNS1 Unknown Plasma membrane, membrane fraction,
membrane
9 2
CPR5 peptidyl-prolyl cis–trans isomerase activity Cytoplasm, endoplasmic reticulum 8.9 3




HXT5 Probable glucose transporter Plasma membrane, membrane fraction,
membrane
8.2 6
YRO2 Unknown Cellular bud, cytoplasm,
mitochondrion
8.1 5
GPM1* Phosphoglycerate mutase Cytoplasm, mitochondrion 8.0 14




KIC1 Serine/threonine-protein kinase Cellular bud, cytoplasm, site of
polarized growth
7.5 2










AGP1 General amino-acid permease Plasma membrane 7.2 2
SLK19 * Kinetochore protein Cytoskeleton, nucleus, chromosome 7.2 2
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Protein Molecular function Cellular distribution sec6-4/sec23-1 Peptides found
YPT7 GTPase activity Membrane, cytoplasm, mitochondrion,
mitochondrial envelope, vacuole
6.4 3
PRC1 Carboxypeptidase C activity Cytoplasm, endoplasmic reticulum,
vacuole
6.3 2
SNC2 Synaptobrevin homolog 2 Cytoplasm, cytoplasmic membrane-
bounded, Golgi apparatus
6.2 4
ENA1 Sodium transport ATPase Plasma membrane, membrane,
membrane fraction
6.1 22
PGK1 ** Phosphoglycerate kinase Cytoplasm, membrane fraction,
mitochondrion
5.8 22
EMP47 * Integral membrane protein Cytoplasm, Golgi apparatus,
cytoplasmic membrane-bounded
5.8 2




TPI1** Triosephosphate isomerase Cytoplasm, membrane fraction,
mitochondrion
5.2 8
KAP123 * Importin subunit beta-4, protein carrier activity Cytoplasm, membrane, endomembrane
system, nucleus
5.1 2
AHP1 Peroxiredoxin Plasma membrane enriched fraction,
cytoplasm
5.0 2
YJL171C Uncharacterized protein Cell wall, cytoplasm, membrane
fraction, mitochondrion
5 2
GCN1 * Translational activator Cytoplasm, mitochondrion, ribosome 4.9 2
SOD1 * Superoxide dismutase Cytoplasm, mitochondrial envelope,
mitochondrion, nucleus
4.8 3
CHS1 Chitin synthase activity Plasma membrane, membrane fraction,
membrane
4.8 2
GPP1 * Glycerol-3-phosphatase Cytoplasm, nucleus 4.8 7
KAR2 Glucose-regulated protein Cytoplasm, endoplasmic reticulum 4.7 9
KRE2 Glycolipid 2-α-mannosyltransferase Cell wall, cytoplasm, Golgi apparatus 4.6 3
CDC42 Cell division control protein, GTPase activity Cellular bud, plasma membrane,
membrane, site of polarized growth
4.5 2
ALD6** Aldehyde dehydrogenase Cytoplasm, mitochondrion 4.4 5
YLR413W Cell membrane protein Unknown 4.4 3
ERG4 * delta24(24-1) sterol reductase activity Cytoplasm, endoplasmic reticulum 4.4 2
GNP1 High-affinity glutamine permease Plasma membrane, cytoplasm,
membrane, mitochondrion
4.4 7
HSP12 12 kDa heat shock protein Plasma membrane, cytoplasm, plasma
membrane enriched fraction, nucleus
4.4 4




PDR15 ATPase activity, coupled to transmembrane
movement of substances
Membrane 4.3 3
PGI1** Glucose-6-phosphate isomerase Cytoplasm, membrane fraction,
mitochondrion
4.3 5
RPL43A** 60S Ribosomal protein L43 Cytoplasm, ribosome 4.2 2
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Protein Molecular function Cellular distribution sec6-4/sec23-1 Peptides found
mitochondrion, mitochondrial
envelope, nucleus
MRH1 Unknown Plasma membrane, membrane fraction,
membrane, cytoplasm, mitochondrion
4.1 2
PDI1 Protein disulfide isomerase Cytoplasm, endoplasmic reticulum 4 13




PDC1 ** Pyruvate decarboxylase Cytoplasm, nucleus 3.9 14
DRS2 Probable phospholipid-transporting ATPase Cytoplasm, trans-Golgi network 3.7 2
KTR3 Probable mannosyltransferase Membrane fraction 3.7 5






SSP120 * Unknown Cytoplasm 3.6 2




GPP2 * (DL)-glycerol-3-phosphatase 2 Cytoplasm, nucleus 3.6 2
TDH3 Glyceraldehyde-3-phosphate dehydrogenase Cell wall, plasma membrane enriched
fraction, cytoplasm, mitochondrion
3.3 15










VMA13 * Vacuolar proton pump subunit H Membrane, cytoplasm, vacuole 3.4 2





DNF1 Probable phospholipid-transporting ATPase Plasma membrane, cytoplasm,
mitochondrion
3.3 5
PTR2 Peptide transporter activity Plasma membrane, membrane fraction,
membrane
3.3 2
KRE6 Beta-glucan synthesis-associated protein Cytoplasm, membrane, endomembrane
system, endoplasmic reticulum, Golgi
apparatus
3.3 2
APE3 * Aminopeptidase Y Cytoplasm, vacuole 3.3 2
PMA1 Plasma membrane ATPase 1 Plasma membrane, membrane fraction,
membrane, cytoplasm, mitochondrion
3.2 27
FBA1 * Fructose-bisphosphate aldolase Cytoplasm, mitochondrion 3.2 7
MSC1 * Meiotic sister chromatid recombination protein Cytoplasm, membrane fraction,
endoplasmic reticulum, mitochondrion
3.2 4
KTR1 α-1,2-mannosyltransferase activity Cytoplasm, Golgi apparatus 3.2 5
YOP1 Unknown Membrane 3.1 3
TSA1 * Peroxiredoxin Cytoplasm 3 2
FKS3 1,3-β-glucan synthase activity Cytoplasm, mitochondrion 3 2
CHS3 Chitin synthase activity Cellular bud, plasma membrane,
cytoplasm, cytoplasmic membrane-
2.9 3













Forsmark et al. Page 27
Protein Molecular function Cellular distribution sec6-4/sec23-1 Peptides found
bounded, membrane fraction,
membrane




ADH1 ** Alcohol dehydrogenase Cytoplasm, membrane fraction 2.9 10




GRX2 * Glutaredoxin-2, thiol-disulfide exchange
intermediate activity
Cytoplasm, mitochondrion 2.8 2
TAT1 Valine/tyrosine/tryptophan amino-acid permease Plasma membrane, membrane 2.8 3
VPH1 Subunit a of vacuolar-ATPase V0 domain Membrane, cytoplasm, vacuole 2.8 8




SSS1 Protein transport protein SSS1 Membrane, endomembrane system,
endoplasmic reticulum, cytosol
2.6 2








RHO1 GTP-binding protein Plasma membrane, cellular bud, site of




Vesicles were prepared as described in Materials and Methods and analyzed by iTRAQ. Annotations were derived from the Gene Ontology
classification system as represented in the SGD yeast GO slim component catalogue (http://www.yeastgenome.org/cgi-bin/GO/goSlimMapper.pl).
Likely contaminants have been indicated based on previously reported sub-cellular localization (*) or on their reported high abundance and
cytosolic localization (**).
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Table 3
Proteins which are less abundant in sro7Δ vesicles than in sec6-4 vesicles
Gene Protein description sro7Δ/sec23 sec6-4/sec23-1 sro7Δ/sec6-4
STL1 Sugar transporter 4.5 15.7 0.3
CWP1 Cell wall protein CWP1 precursor 16.1 50.1 0.3
PIR1 Protein PIR1 precursor 13.2 34.0 0.4
YGP1 Protein YGP1 precursor 11.5 29.5 0.4
PRC1 Carboxypeptidase Y precursor 2.9 6.3 0.5
SNC2 Synaptobrevin homolog 2 3.5 6.2 0.6
VPS21 Vacuolar protein sorting-associated protein 21 4.0 6.8 0.6
HXT7 High-affinity hexose transporter 6.2 10.4 0.6
BGL2 Glucan 1,3-beta-glucosidase precursor 9.3 15.6 0.6
CRH1 Probable glycosidase CRH1 precursor 8.4 13.5 0.6
PNS1 Protein PNS1 5.6 9.0 0.6
YPT31 GTP-binding protein 4.9 7.8 0.6
GAS5 Glycolipid-anchored surface protein 5 precursor 9.8 14.7 0.7
SLK19* Kinetochore protein 4.8 7.2 0.7
YNL194C Uncharacterized plasma membrane protein YNL194C 2.4 3.6 0.7
EHT1* Medium-chain fatty acid ethyl ester synthase/esterase 2 8.9 13.2 0.7
PHM7 Phosphate metabolism protein 7 6.3 9.2 0.7
SEC4 Ras-related protein 5.1 7.3 0.7
AGP1 General amino-acid permease 5.0 7.2 0.7
YPT1 GTP-binding protein 6.7 9.4 0.7
PST1 Cell wall mannoprotein PST1 precursor 8.8 12.3 0.7
ENA1 Sodium transport ATPase 1 4.4 6.1 0.7
The proteins were ranked according to their relative abundance in sro7Δ and sec6-4 vesicles, starting with the lowest sro7Δ/sec6-4 ratio.
Annotations are from the SGD yeast GO slim component catalogue (http://www.yeastgenome.org/cgi-bin/GO/goSlimMapper.pl).
Traffic. Author manuscript; available in PMC 2014 February 17.
